Edit |   |
---|---|
Antigenic Specificity | Tibulizumab (IL17A/TNFSF13B/CD257) - (biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG4-kappa-[scFv]2 |
Format | unconjugated |
Size | 0.1 mg |
Concentration | batch dependent |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Tibulizumab (IL17A/TNFSF13B/CD257) - Research Grade Biosimilar Antibody |
Immunogen | Humanized / IL17A/TNFSF13B/CD257 [Homo sapiens] |
Other Names | LY 3090106,LY-3090106,LY3090106 |
Gene, Accession # | n/a |
Catalog # | orb1237316 |
Price | $855 |
Order / More Info | Tibulizumab (IL17A/TNFSF13B/CD257) - (biosimilar) Antibody from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558